AAV Gene Therapy Study for Subjects with PKU
Clinical trial NCT04480567 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04480567
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-24
- Primary completion
- 2027-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.